10 Results

People

  1. Motzer
    Motzer
  2. Voss
    Voss
  3. Feldman
    Feldman
  4. Hakimi
    Hakimi
  5. Carlo
    Carlo
  6. Coleman
    Coleman
  7. Kotecha
    Kotecha
  8. Lee
    Lee
  9. Reese
    Reese
  10. Russo
    Russo

Groups

  1. Department of Medicine (10)
  2. Genitourinary Oncology Service (10)
  3. Solid Tumor Oncology Division (10)
  4. Surgery (4)
  5. Urology (4)
  6. Survivorship Research (3)
  7. Biostatistics Service (2)
  8. Epidemiology and Biostatistics (2)
  9. GME, Urology (2)
  10. Graduate Medical Education (2)
  1. "clinical outcome"
  2. "Robert Motzer"
Formats
  1. Journal Article (9)
  2. Correspondence (1)
Groups
  1. Department of Medicine (10)
  2. Genitourinary Oncology Service (10)
  3. Solid Tumor Oncology Division (10)
  4. Surgery (4)
  5. Urology (4)
  6. Survivorship Research (3)

More Groups

People
  1. Robert Motzer (10)
  2. Martin Voss (4)
  3. Abraham Hakimi (3)
  4. Chung-Han Lee (3)
  5. Darren Feldman (3)
  6. Jonathan Coleman (2)

More People

Years
  1. 2024 (1)
  2. 2023 (3)
  3. 2022 (1)
  4. 2021 (1)
  5. 2020 (1)
  6. 2019 (1)

More Years

Publications
  1. European Urology (2)
  2. Urologic Oncology: Seminars and Original Investigations (2)
  3. British Journal of Cancer (1)
  4. Cancer (1)
  5. Clinical Genitourinary Cancer (1)
  6. European Urology Open Science (1)

More Publications

Publishers
  1. Elsevier Science, Inc. (4)
  2. Elsevier Inc. (3)
  3. Elsevier B.V. (1)
  4. Nature Publishing Group (1)
  5. Wiley Blackwell (1)

Results (10)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Surgical outcomes of cytoreductive nephrectomy in patients receiving systemic immunotherapy for advanced renal cell carcinoma
    Journal Article

    Reese, S. W.; Eismann, L.; White, C.; Arroyave Villada, J.; Khaleel, S.; Ostrovnaya, I.; Vazquez-Rivera, K.; Carlo, M. I.; Feldman, D.; Lee, C. H.; more...
    Urologic Oncology: Seminars and Original Investigations (2024)

    Fulltext@MSK | Save
  • Real-world clinical outcomes of patients with metastatic renal cell carcinoma receiving pembrolizumab + axitinib vs. ipilimumab + nivolumab
    Journal Article

    Shah, N. J.; Sura, S. D.; Shinde, R.; Shi, J.; Singhal, P.; Perini, R. F.; Motzer, R. J.
    Urologic Oncology: Seminars and Original Investigations (2023)

    Fulltext@MSK | Save
  • Reply by authors
    Correspondence

    Reese, S. W.; Khaleel, S.; Silagy, A.; Xie, A.; Eismann, L.; Vazquez-Rivera, K.; Oparanozie, A.; Patil, S.; Coleman, J.; Motzer, R.; more...
    Journal of Urology (2023)

    Fulltext@MSK | Save
  • Real-world treatment patterns and clinical outcomes for metastatic renal cell carcinoma in the current treatment era
    Journal Article

    Shah, N. J.; Sura, S. D.; Shinde, R.; Shi, J.; Singhal, P. K.; Robert, N. J.; Vogelzang, N. J.; Perini, R. F.; Motzer, R. J.
    European Urology Open Science (2023)

    Fulltext@MSK | Save
  • Conditional survival and long-term efficacy with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma
    Journal Article

    Motzer, R. J.; McDermott, D. F.; Escudier, B.; Burotto, M.; Choueiri, T. K.; Hammers, H. J.; Barthélémy, P.; Plimack, E. R.; Porta, C.; George, S.; more...
    Cancer (2022)

    Fulltext@MSK | Save
  • Correlative serum biomarker analyses in the phase 2 trial of lenvatinib-plus-everolimus in patients with metastatic renal cell carcinoma
    Journal Article

    Lee, C. H.; Motzer, R. J.; Glen, H.; Michaelson, M. D.; Larkin, J.; Minoshima, Y.; Kanekiyo, M.; Ikezawa, H.; Sachdev, P.; Dutcus, C. E.; more...
    British Journal of Cancer (2021)

    Fulltext@MSK | Save
  • Efficacy of nivolumab plus ipilimumab according to number of IMDC risk factors in CheckMate 214
    Journal Article

    Escudier, B.; Motzer, R. J.; Tannir, N. M.; Porta, C.; Tomita, Y.; Maurer, M. A.; McHenry, M. B.; Rini, B. I.
    European Urology (2020)

    Fulltext@MSK | Save
  • Surgical management of patients with advanced germ cell tumors following salvage chemotherapy: Memorial Sloan Kettering Cancer Center (MSKCC) experience
    Journal Article

    Miller, M. I.; Feifer, A.; Feldman, D. R.; Carver, B. S.; Bosl, G. J.; Motzer, R. J.; Bajorin, D. F.; Sheinfeld, J.
    Urology (2019)

    Fulltext@MSK | Save
  • CheckMate 025 randomized phase 3 study: Outcomes by key baseline factors and prior therapy for nivolumab versus everolimus in advanced renal cell carcinoma
    Journal Article

    Escudier, B.; Sharma, P.; McDermott, D. F.; George, S.; Hammers, H. J.; Srinivas, S.; Tykodi, S. S.; Sosman, J. A.; Procopio, G.; Plimack, E. R.; more...
    European Urology (2017)

    Fulltext@MSK | Save
  • Genomic characterization of renal medullary carcinoma and treatment outcomes
    Journal Article

    Carlo, M. I.; Chaim, J.; Patil, S.; Kemel, Y.; Schram, A. M.; Woo, K.; Coskey, D.; Nanjangud, G. J.; Voss, M. H.; Feldman, D. R.; more...
    Clinical Genitourinary Cancer (2017)

    Fulltext@MSK | Save